Development of Japanese Versions of the 4‐Item Mystical Experience Questionnaire and 7‐Item Challenging Experience Questionnaire

{"INTRODUCTION:":[0],"Interest":[1],"in":[2,113,209],"therapeutic":[3],"applications":[4],"of":[5,63,82,85,101,123,150,162,176,189],"psychedelics":[6,18,114],"has":[7],"recently":[8],"resurged.":[9],"Mystical-type":[10],"and":[11,29,42,66,73,91,108,118,121,153,157,165,179,186,191,207],"challenging":[12,192],"experiences":[13,193],"that":[14],"are":[15,19],"elicited":[16],"by":[17,79],"commonly":[20],"assessed":[21],"using":[22],"the":[23,30,64,71,80,83,89,102,119,124,151,158,163,171,177],"30-item":[24],"Mystical":[25],"Experience":[26,33],"Questionnaire":[27,34],"(MEQ-30)":[28],"26-item":[31],"Challenging":[32],"(CEQ),":[35],"respectively.":[36],"The":[37,145],"brief":[38],"4-item":[39],"MEQ":[40],"(MEQ-4)":[41],"7-item":[43],"CEQ":[44],"(CEQ-7)":[45],"may":[46],"reduce":[47],"respondent":[48],"burden,":[49],"but":[50],"Japanese":[51,61,125,160,174,195],"versions":[52,62,149,161,175],"have":[53],"not":[54,130,142],"yet":[55],"been":[56],"developed.":[57],"This":[58],"study":[59],"developed":[60],"MEQ-4":[65,72,152,164,178],"CEQ-7.":[67],"METHODS:":[68],"In":[69,170],"translating":[70],"CEQ-7,":[74],"our":[75],"procedures":[76],"were":[77,155,167,181],"informed":[78],"recommendations":[81],"\\"Principles":[84],"Good":[86],"Practice":[87],"for":[88,95,106],"Translation":[90,107],"Cultural":[92,109],"Adaptation":[93],"Process":[94],"Patient-Reported":[96],"Outcomes":[97],"(PRO)":[98],"Measures:":[99],"Report":[100],"ISPOR":[103],"Task":[104],"Force":[105],"Adaptation.\\"":[110],"Separately,":[111],"experts":[112],"reviewed":[115],"semantic":[116],"nuances":[117],"naturalness":[120],"appropriateness":[122],"wording.":[126],"Cognitive":[127],"debriefing":[128],"was":[129,141],"conducted":[131],"because":[132],"recruiting":[133],"an":[134],"appropriate":[135],"Japanese-speaking":[136,210],"sample":[137],"with":[138],"psychedelic":[139],"experience":[140],"feasible.":[143],"RESULTS:":[144],"final,":[146],"approved":[147],"back-translated":[148],"CEQ-7":[154,166,180],"developed,":[156,182],"authorized":[159],"established.":[168],"CONCLUSIONS:":[169],"present":[172],"study,":[173],"enabling":[183],"more":[184],"rapid":[185],"efficient":[187],"assessments":[188],"mystical":[190],"among":[194],"speakers.":[196],"Future":[197],"studies":[198],"should":[199],"evaluate":[200],"their":[201],"comprehensibility,":[202],"interpretability,":[203],"cultural":[204],"appropriateness,":[205],"reliability,":[206],"validity":[208],"samples.":[211]}

Authors

Institutions

Publication Details

Journal
Neuropsychopharmacology Reports
Published
2026-08-27
DOI
https://doi.org/10.1002/npr2.70164
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Development of Japanese Versions of the 4‐Item Mystical Experience Questionnaire and 7‐Item Challenging Experience Questionnaire

Futaba Umemura, Hiroko Kotajima‐Murakami, Justin C. Strickland, Matthew W. Johnson et al.
Neuropsychopharmacology Reports
Psychedelics and Drug Studies
article

Development of Japanese Versions of the 4‐Item Mystical Experience Questionnaire and 7‐Item Challenging Experience Questionnaire

Futaba Umemura, Hiroko Kotajima‐Murakami, Justin C. Strickland, Matthew W. Johnson, Kazutaka Ikeda, Albert Garcia‐Romeu
article en

Abstract

INTRODUCTION: Interest in therapeutic applications of psychedelics has recently resurged. Mystical-type and challenging experiences that are elicited by psychedelics are commonly assessed using the 30-item Mystical Experience Questionnaire (MEQ-30) and the 26-item Challenging Experience Questionnaire (CEQ), respectively. The brief 4-item MEQ (MEQ-4) and 7-item CEQ (CEQ-7) may reduce respondent burden, but Japanese versions have not yet been developed. This study developed Japanese versions of the MEQ-4 and CEQ-7. METHODS: In translating the MEQ-4 and CEQ-7, our procedures were informed by the recommendations of the "Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation." Separately, experts in psychedelics reviewed semantic nuances and the naturalness and appropriateness of the Japanese wording. Cognitive debriefing was not conducted because recruiting an appropriate Japanese-speaking sample with psychedelic experience was not feasible. RESULTS: The final, approved back-translated versions of the MEQ-4 and CEQ-7 were developed, and the authorized Japanese versions of the MEQ-4 and CEQ-7 were established. CONCLUSIONS: In the present study, Japanese versions of the MEQ-4 and CEQ-7 were developed, enabling more rapid and efficient assessments of mystical and challenging experiences among Japanese speakers. Future studies should evaluate their comprehensibility, interpretability, cultural appropriateness, reliability, and validity in Japanese-speaking samples.

Neuropsychopharmacology ReportsVol. 46(3)
University of Maryland, Baltimore (US), Johns Hopkins University (US), Johns Hopkins Medicine (US), Tokyo Metropolitan Institute of Medical Science (JP), National Center of Neurology and Psychiatry (JP), National Institute of Mental Health (JP), Niigata University (JP)
Tokyo Medical and Dental University, Japan Society for the Promotion of Science
Quality Education
Openalex Percentile: Top 6%
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.